Back

RBC raises Oxford Nanopore target to 300p from 225p

Verifying
  • RBC Capital Markets increased its target price for Oxford Nanopore Technologies.
  • The target rose to 300p from 225p.
  • RBC cited rising biological-data demand linked to AI advances in drug discovery.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.